Colin Germond

984 total citations
21 papers, 794 citations indexed

About

Colin Germond is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Colin Germond has authored 21 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Epidemiology. Recurrent topics in Colin Germond's work include Cancer Treatment and Pharmacology (10 papers), Colorectal Cancer Treatments and Studies (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). Colin Germond is often cited by papers focused on Cancer Treatment and Pharmacology (10 papers), Colorectal Cancer Treatments and Studies (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). Colin Germond collaborates with scholars based in Canada, United States and Germany. Colin Germond's co-authors include T.K. Yeung, Zhixiang Wang, Xinmei Chen, Pablo Cano, Malcolm J. Moore, Eric Van Cutsem, Stefan Glück, Jonathan Noble, Juan W. Valle and Clive Sinoff and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Colin Germond

19 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Colin Germond Canada 12 500 214 161 131 103 21 794
Paul Thompson New Zealand 20 311 0.6× 376 1.8× 165 1.0× 99 0.8× 59 0.6× 44 1.1k
Chiara De Divitiis Italy 13 410 0.8× 136 0.6× 102 0.6× 99 0.8× 53 0.5× 24 641
Ming‐Shen Dai Taiwan 17 278 0.6× 206 1.0× 171 1.1× 83 0.6× 25 0.2× 71 771
A.S.T. Planting Netherlands 19 681 1.4× 333 1.6× 236 1.5× 170 1.3× 35 0.3× 31 1.2k
Merry Tetef United States 14 269 0.5× 147 0.7× 119 0.7× 30 0.2× 67 0.7× 29 581
Diana Stempak Canada 16 254 0.5× 380 1.8× 202 1.3× 46 0.4× 269 2.6× 22 975
Lorrin Yee United States 17 514 1.0× 446 2.1× 128 0.8× 49 0.4× 18 0.2× 37 1.0k
K Nakanishi Japan 19 189 0.4× 350 1.6× 133 0.8× 91 0.7× 27 0.3× 61 988
Muhammad Salim United States 15 698 1.4× 260 1.2× 250 1.6× 124 0.9× 24 0.2× 42 1.1k

Countries citing papers authored by Colin Germond

Since Specialization
Citations

This map shows the geographic impact of Colin Germond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Germond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Germond more than expected).

Fields of papers citing papers by Colin Germond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin Germond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Germond. The network helps show where Colin Germond may publish in the future.

Co-authorship network of co-authors of Colin Germond

This figure shows the co-authorship network connecting the top 25 collaborators of Colin Germond. A scholar is included among the top collaborators of Colin Germond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin Germond. Colin Germond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cutsem, Eric Van, Emilio Bajetta, Juan W. Valle, et al.. (2011). Randomized, Placebo-Controlled, Phase III Study of Oxaliplatin, Fluorouracil, and Leucovorin With or Without PTK787/ZK 222584 in Patients With Previously Treated Metastatic Colorectal Adenocarcinoma. Journal of Clinical Oncology. 29(15). 2004–2010. 124 indexed citations
2.
Alkhayyat, Shadi, Susan Dent, Jean Verreault, et al.. (2009). Incidence of Febrile Neutropenia with Taxane-Based Systemic Therapy in Women with Early Stage Breast Cancer.. Cancer Research. 69(24_Supplement). 2087–2087. 2 indexed citations
3.
4.
Maroun, J., Walter Kocha, Larry K. Kvols, et al.. (2006). Guidelines for the Diagnosis and Management of Carcinoid Tumours. Part 1: The Gastrointestinal Tract. A Statement from a Canadian National Carcinoid Expert Group. Current Oncology. 13(2). 67–76. 70 indexed citations
5.
6.
7.
Maroun, Jean A., Walter Kocha, Larry K. Kvols, et al.. (2006). Guidelines for the diagnosis and management of carcinoid tumours. Part 1: the gastrointestinal tract. A statement from a Canadian National Carcinoid Expert Group.. PubMed. 13(2). 67–76. 63 indexed citations
8.
Fields, Anthony, David Rinaldi, Charles Henderson, et al.. (2005). An open-label multicenter phase II study of oral lapatinib (GW572016) as single agent, second-line therapy in patients with metastatic colorectal cancer. Journal of Clinical Oncology. 23(16_suppl). 3583–3583. 43 indexed citations
9.
Germond, Colin, et al.. (2004). A phase II clinical trial involving the use of low-dose daily oral cyclophosphamide, weekly vinblastine and rofecoxib in patients with advanced solid tumors. Journal of Clinical Oncology. 22(14_suppl). 3137–3137. 1 indexed citations
10.
Niculescu, Radu Stefan, et al.. (2003). Clinical and financial outcomes analysis with existing hospital patient records. 1 indexed citations
11.
Yeung, T.K., Colin Germond, Xinmei Chen, & Zhixiang Wang. (1999). The Mode of Action of Taxol: Apoptosis at Low Concentration and Necrosis at High Concentration. Biochemical and Biophysical Research Communications. 263(2). 398–404. 134 indexed citations
12.
Bjarnason, Georg A., C. Cripps, Rakesh Goel, et al.. (1998). Phase I-II Study of 5-Fluorouracil, Leucovorin, Doxorubicin, Methotrexate, and Long-Term Oral Etoposide (FLAME) in Unresectable or Metastatic Gastric Cancer. American Journal of Clinical Oncology. 21(6). 537–542.
13.
Glück, Stefan, Colin Germond, Pedro López, et al.. (1998). A phase I trial of high-dose paclitaxel, cyclophosphamide and mitoxantrone with autologous blood stem cell support for the treatment of metastatic breast cancer. European Journal of Cancer. 34(7). 1008–1014. 19 indexed citations
14.
Yau, Jonathan C., Colin Germond, Stefan Glück, et al.. (1998). Mitoxantrone, prednimustine, and vincristine for elderly patients with aggressive non-Hodgkin's lymphoma. American Journal of Hematology. 59(2). 156–160. 6 indexed citations
15.
Glück, Stefan, et al.. (1997). High-dose chemotherapy followed by autologous blood cell transplantation: a safe and effective outpatient approach. Bone Marrow Transplantation. 20(6). 431–434. 35 indexed citations
16.
Vincent, Mark, Glen Goss, Clive Sinoff, et al.. (1994). Bi-weekly vincristine, epirubicin and methylprednisolone in alkylator-refractory multiple myeloma. Cancer Chemotherapy and Pharmacology. 34(4). 356–360. 2 indexed citations
17.
Goss, Glenwood, et al.. (1993). Combination Chemotherapy with Teniposide (VM26) and Carboplatin in Small Cell Lung Cancer. American Journal of Clinical Oncology. 16(4). 295–300. 6 indexed citations
18.
Ho, Anthony D., et al.. (1993). Optimal timing for collections of blood progenitor cells following induction chemotherapy and granulocyte-macrophage colony-stimulating factor for autologous transplantation in advanced breast cancer.. PubMed. 7(11). 1738–46. 55 indexed citations
19.
Skillings, Jamey, MN Levine, E. Eisenhauer, et al.. (1991). Levamisole and 5-fluorouracil therapy for resected colon cancer: a new indication.. PubMed. 144(3). 297–301. 8 indexed citations
20.
Lewis, Michael I., et al.. (1983). Survival following massive overdose of adrenergic blocking agents (acebutolol and labetalol). European Heart Journal. 4(5). 328–332. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Thompson Breakdown of academic impact, for papers by Chiara De Divitiis Breakdown of academic impact, for papers by Ming‐Shen Dai Breakdown of academic impact, for papers by A.S.T. Planting Breakdown of academic impact, for papers by Merry Tetef Breakdown of academic impact, for papers by Diana Stempak Breakdown of academic impact, for papers by Lorrin Yee Breakdown of academic impact, for papers by K Nakanishi Breakdown of academic impact, for papers by Muhammad Salim
Rankless by CCL
2026